Page last updated: 2024-08-23

zidovudine and acriflavine

zidovudine has been researched along with acriflavine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourut, C; Chenu, E; Mathé, G; Orbach-Arbouys, S; Pontiggia, P1
Ambetima, N; Blanquet, D; Hallard, M; Mathé, G; Morette, C; Orbach-Arbouys, S; Pontiggia, P; Triana, K1
Blanquet, D; Hallard, M; Mathé, G; Morette, C; Pontiggia, P; Triana, K1
Blanquet, D; Hage, F; Hallard, M; Mathe, G; Morette, C; Pontiggia, P1

Reviews

1 review(s) available for zidovudine and acriflavine

ArticleYear
Data of pre-clinical and early clinical trials of acriflavine and hydroxy-methyl-ellipticine reviewed, enriched by the experience of their use for 18 months to 6 years in combinations with other HIV1 virostatics.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1998, Volume: 52, Issue:9

    Topics: Acriflavine; Anti-HIV Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Ellipticines; HIV Infections; Humans; Treatment Outcome; Zidovudine

1998

Trials

1 trial(s) available for zidovudine and acriflavine

ArticleYear
AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1996, Volume: 50, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Acriflavine; Adult; Anti-Infective Agents; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Ellipticines; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Zalcitabine; Zidovudine

1996

Other Studies

2 other study(ies) available for zidovudine and acriflavine

ArticleYear
In vivo eradication of Friend virus as an experimental HIV-model, by combination of zidovudine, acriflavine and an ellipticine analogue. Possible application to the treatment of human pre-AIDS?
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1994, Volume: 48, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Acriflavine; AIDS-Related Complex; Animals; Drug Therapy, Combination; Ellipticines; Friend murine leukemia virus; HIV Infections; Humans; Male; Mice; Mice, Inbred DBA; Zidovudine

1994
Viral and immunologic follow up of 4 to 9 years of AIDS treatments by quadruple combinations of virostatics including integrase inhibitors applied in short sequences differing by drug rotation.
    Acta pharmacologica Sinica, 2002, Volume: 23, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Acriflavine; Adult; Anti-HIV Agents; Antiviral Agents; CD4-CD8 Ratio; Didanosine; Drug Therapy, Combination; Ellipticines; Female; Follow-Up Studies; HIV-1; Humans; Integrase Inhibitors; Male; Middle Aged; Protease Inhibitors; Stavudine; Vitamin B 12; Zalcitabine; Zidovudine

2002